The rotavirus vaccine saga (Q36366831)

13 August 2017

1 reference

title

The rotavirus vaccine saga (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

Alan R Shaw

1

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Annual Review of Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

57

1 reference

13 August 2017

issue

1

0 references

page(s)

167-180

1 reference

Lack of an apparent association between intussusception and wild or vaccine rotavirus infection

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Serum antibody as a marker of protection against natural rotavirus infection and disease

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Lifesaving vaccine caught in an ethical minefield

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Letter: Evidence for viral gastroenteritis.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Cardiac embryology. Its relevance to congenital heart disease

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Review of rotavirus vaccine trials in Finland

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Interactions between rotavirus and gastrointestinal cells

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Ecological studies, rotavirus vaccination, and intussusception.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Urinary myiasis associated with ureteral stent placements

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Rotavirus-Specific Helper T Cell Responses in Newborns, Infants, Children, and Adults

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Safety and Immunogenicity of Human Rotavirus Vaccine Strain M37 in Adults, Children, and Infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Development of an improved method for measuring neutralizing antibody to rotavirus

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Evaluation of a bovine-human rotavirus reassortant vaccine in infants

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Reassortant formation and selection following coinfection of cultured cells with subgroup 2 human rotaviruses

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Molecular and immunological methods to detect rotavirus in formalin-fixed tissue

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Reassortant rotaviruses as potential live rotavirus vaccine candidates

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Early phase II trial of human rotavirus vaccine candidate RV3

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

Intussusception Among Recipients of Rotavirus Vaccine—United States, 1998-1999

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

PRELIMINARY EVALUATION OF THE EFFICACY OF RHESUS ROTAVIRUS VACCINE STRAIN MMU 18006 IN YOUNG CHILDREN

8 October 2022

1 reference

https://api.crossref.org/works/10.1146/ANNUREV.MED.57.121304.131359

10.1146/ANNUREV.MED.57.121304.131359

8 October 2022

Identifiers

DOI

1 reference

13 August 2017

1 reference